Family Factors of Eating Habits Among Adolescents
Launched by THE UNIVERSITY OF HONG KONG · Mar 4, 2020
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
Background:
Healthy lifestyle is a key preventive approach to combat the rising prevalence of non-communicable diseases (NCD) worldwide\], among which diet is highlighted as a modifiable risk factor of the most common NCD, namely hypertension, diabetes mellitus and coronary heart disease. Adolescence is a transitioning stage from parent-dependence to increasing autonomy in behavior including healthy or risky behavior. The dietary habit established in this period has high tendency to continue to adulthood.
Many national dietary recommendations were established to promote quality diet in or...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Family with an adolescent aged 10-19 by 31 December 2019
- • At least one adolescent from the family had completed dietary intake survey on or before 31 December 2019
- • Both parent and child have given written consent
- Exclusion Criteria:
- • Parent or child cannot speak Cantonese
- • Neither parent is the primary caregiver of the child
Trial Officials
Cindy Lo Kuen Lam, MBBS
Principal Investigator
The University of Hong Kong
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials